NasdaqCM - Nasdaq Real Time Price USD

Organogenesis Holdings Inc. (ORGO)

Compare
3.1100 -0.0500 (-1.58%)
At close: October 21 at 4:00 PM EDT
3.1100 0.00 (0.00%)
After hours: October 21 at 4:02 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
448,392.0000
433,140.0000
450,893.0000
467,359.0000
338,298.0000
--
Cost of Revenue
111,452.0000
106,481.0000
105,019.0000
114,199.0000
87,319.0000
--
Gross Profit
336,940.0000
326,659.0000
345,874.0000
353,160.0000
250,979.0000
--
Operating Expense
325,102.0000
314,134.0000
323,570.0000
280,942.0000
224,279.0000
--
Operating Income
11,838.0000
12,525.0000
22,304.0000
72,218.0000
26,700.0000
--
Net Non Operating Interest Income Expense
-2,081.0000
-2,190.0000
-2,009.0000
-7,236.0000
-11,279.0000
--
Other Income Expense
-22,800.0000
57.0000
-13.0000
-1,896.0000
2,343.0000
--
Pretax Income
-13,043.0000
10,392.0000
20,282.0000
63,086.0000
17,764.0000
--
Tax Provision
3,502.0000
5,447.0000
4,750.0000
-31,116.0000
530.0000
--
Net Income Common Stockholders
-16,545.0000
4,945.0000
15,532.0000
94,202.0000
17,234.0000
--
Diluted NI Available to Com Stockholders
-16,545.0000
4,945.0000
15,532.0000
94,202.0000
17,234.0000
--
Basic EPS
-0.12
0.04
0.12
0.74
0.17
--
Diluted EPS
-0.12
0.04
0.12
0.71
0.16
--
Basic Average Shares
131,745.3460
131,231.3170
130,070.2310
128,331.0220
107,737.9360
--
Diluted Average Shares
132,617.5040
132,746.7270
132,383.1520
133,662.6590
111,360.8310
--
Total Operating Income as Reported
-10,963.0000
12,525.0000
22,304.0000
72,218.0000
26,700.0000
--
Total Expenses
436,554.0000
420,615.0000
428,589.0000
395,141.0000
311,598.0000
--
Net Income from Continuing & Discontinued Operation
-16,545.0000
4,945.0000
15,532.0000
94,202.0000
17,234.0000
--
Normalized Income
1,467.7900
4,945.0000
15,532.0000
95,576.5900
15,053.1340
--
Interest Expense
2,081.0000
2,190.0000
2,009.0000
7,236.0000
11,279.0000
--
Net Interest Income
-2,081.0000
-2,190.0000
-2,009.0000
-7,236.0000
-11,279.0000
--
EBIT
-10,962.0000
12,582.0000
22,291.0000
70,322.0000
29,043.0000
--
EBITDA
13,279.0000
36,031.0000
40,322.0000
86,998.0000
37,226.0000
--
Reconciled Cost of Revenue
111,452.0000
106,481.0000
105,019.0000
114,199.0000
87,319.0000
--
Reconciled Depreciation
24,241.0000
23,449.0000
18,031.0000
16,676.0000
8,183.0000
--
Net Income from Continuing Operation Net Minority Interest
-16,545.0000
4,945.0000
15,532.0000
94,202.0000
17,234.0000
--
Total Unusual Items Excluding Goodwill
-22,801.0000
--
--
-1,883.0000
2,246.0000
--
Total Unusual Items
-22,801.0000
--
--
-1,883.0000
2,246.0000
--
Normalized EBITDA
36,080.0000
36,031.0000
40,322.0000
88,881.0000
34,980.0000
--
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0000
--
Tax Effect of Unusual Items
-4,788.2100
--
--
-508.4100
65.1340
--
12/31/2019 - 1/5/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers